Gabapentin Effect on Pain Associated with Heroin Withdrawal in Iranian Crack: a Randomized Double-blind Clinical Trial

PMC full text:

Copyright/License ►Request permission to reuse: Copyright © 2012 by School of Pharmacy, Shaheed Beheshti University of Medical Sciences and Health Services
This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (http://creativecommons.org/licenses/by/3.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Table 2

Severity of pain based on SOWS scale in gabapentin and placebo group

Characteristics	Gabapentin group (n = 30)	Placebo group (n = 30)	p-value
First day	1.43 ± 1.04	3.77 ± 0.50	< 0.001
Second day	1.27 ± 0.74	3.57 ± 0.57	< 0.001
Third day	0.93 ± 0.74	3.20 ± 0.76	< 0.001
Forth day	0.83 ± 0.70	2.73 ± 0.69	< 0.001
Fifth day	0.37 ± 0.62	2.13 ± 0.86	< 0.001
Sixth day	0.07 ± 0.37	0.60 ± 0.93	0.003
Seventh day	0.03 ± 0.18	0.10 ± 0.31	0.305